Atea is a tiny firm with a $three billion market cap. Shares of Merck NYSE: MRK ran up 9%, and Atea Pharmaceuticals NASDAQ: AVIR flew 20% larger. The capsule, made by Merck and Ridgeback Biotherapeutics, is designed to deal with mild to reasonable COVID-19 in adults who are in danger of having extreme COVID-19 or […]
Headline
Tag: Molnupiravir
Back To Top